Literature DB >> 9287071

Periodontal considerations in the management of the cancer patient. Committee on Research, Science and Therapy of the American Academy of Periodontology.

.   

Abstract

This position paper on periodontal considerations in the management of the cancer patient was prepared by the Research, Science and Therapy Committee of The American Academy of Periodontology. It is intended to provide information regarding the effects of head and neck radiation, total body radiation, chemotherapy, and bone marrow transplantation on the oral tissues. In addition, the paper offers suggestions for the prevention and treatment of periodontal and oral side effects of cancer therapy. Reliance on this position paper for patient management will not guarantee a successful outcome. Cancer therapy may be associated with complex problems. Ultimately, decisions regarding the diagnosis and treatment of oral disease in an individual patient must be made by the treating practitioner in light of the specific facts presented by that patient and in consultation with the patient's physician.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287071

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  3 in total

Review 1.  A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 2.

Authors:  H Jawad; N A Hodson; P J Nixon
Journal:  Br Dent J       Date:  2015-01       Impact factor: 1.626

2.  Clinical evaluation with 18 months follow-up of new PTTM enhanced dental implants in maxillo-facial post-oncological patients.

Authors:  Piero Papi; Sara Jamshir; Edoardo Brauner; Stefano Di Carlo; Antonio Ceci; Luca Piccoli; Giorgio Pompa
Journal:  Ann Stomatol (Roma)       Date:  2015-02-09

3.  Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors.

Authors:  Stefan Wuketich; Stefan A Hienz; Christine Marosi
Journal:  Support Care Cancer       Date:  2011-02-18       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.